covid-19 testing vaccine

Potential COVID-19 antiviral drug being tested in humans after proving effective in hamster study

Reading now: 778
www.fox29.com

statement.The experimental drug, delivered only orally, is now being tested in human clinical trials by Ridgeback Biotherapeutics and pharmaceutical company Merck.

Remdesivir, a different antiviral drug already approved by the U.S. Food and Drug Administration, can only be provided intravenously.Scientists said they found MK-4482 proved to be effective when given up to 12 hours before, or 12 hours after, the hamsters were injected with the coronavirus. RELATED: Pfizer begins phase 1 study of oral COVID-19 treatment drugThe latest study involved three groups of hamsters: a pre-infection treatment group, a post-infection treatment group and an untreated control group.

Read more on fox29.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA